Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia De Lorenzo

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
The FEBS Journal|February 18, 2009
Human anti-ErbB2 immunoagents--immunoRNases and compact antibodiesClaudia De Lorenzo, Giuseppe D'Alessio
Current Pharmaceutical Biotechnology|August 5, 2008
From immunotoxins to immunoRNasesClaudia De Lorenzo, Giuseppe D'Alessio
International Journal of Molecular Sciences|August 27, 2021
Interactions of Spike-RBD of SARS-CoV-2 and Platelet Factor 4: New Insights in the Etiopathogenesis of ThrombosisMargherita Passariello, Cinzia Vetrei, Felice Amato, et al.
Anesthesia and Analgesia|March 23, 2006
Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%Claudia De Lorenzo, Andreas Calatzis, Ulrich Welsch, et al.
FEBS Letters|April 18, 2002
A new RNase-based immunoconjugate selectively cytotoxic for ErbB2-overexpressing cellsClaudia De Lorenzo, Alessandra Nigro, Renata Piccoli, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 9, 2008
A novel human antitumor dimeric immunoRNaseGennaro Riccio, Marianna Borriello, Giuseppe D'Alessio, et al.
Protein Engineering, Design & Selection : PEDS|December 13, 2012
A novel fully human antitumor immunoRNase resistant to the RNase inhibitorGennaro Riccio, Chiara D'Avino, Ronald T Raines, et al.
Cancers|September 1, 2019
Novel Human Bispecific Aptamer-Antibody Conjugates for Efficient Cancer Cell KillingMargherita Passariello, Simona Camorani, Cinzia Vetrei, et al.
The FEBS Journal|September 18, 2008
Differential binding of human immunoagents and Herceptin to the ErbB2 receptorFulvia Troise, Valeria Cafaro, Concetta Giancola, et al.
Breast Cancer Research and Treatment|June 8, 2012
Mechanisms of cardiotoxicity associated with ErbB2 inhibitorsCarmine Fedele, Gennaro Riccio, Angela Eliana Malara, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
The FEBS Journal|February 18, 2009
Human anti-ErbB2 immunoagents--immunoRNases and compact antibodiesClaudia De Lorenzo, Giuseppe D'Alessio
Current Pharmaceutical Biotechnology|August 5, 2008
From immunotoxins to immunoRNasesClaudia De Lorenzo, Giuseppe D'Alessio
International Journal of Molecular Sciences|August 27, 2021
Interactions of Spike-RBD of SARS-CoV-2 and Platelet Factor 4: New Insights in the Etiopathogenesis of ThrombosisMargherita Passariello, Cinzia Vetrei, Felice Amato, et al.
Anesthesia and Analgesia|March 23, 2006
Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%Claudia De Lorenzo, Andreas Calatzis, Ulrich Welsch, et al.
FEBS Letters|April 18, 2002
A new RNase-based immunoconjugate selectively cytotoxic for ErbB2-overexpressing cellsClaudia De Lorenzo, Alessandra Nigro, Renata Piccoli, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 9, 2008
A novel human antitumor dimeric immunoRNaseGennaro Riccio, Marianna Borriello, Giuseppe D'Alessio, et al.
Protein Engineering, Design & Selection : PEDS|December 13, 2012
A novel fully human antitumor immunoRNase resistant to the RNase inhibitorGennaro Riccio, Chiara D'Avino, Ronald T Raines, et al.
Cancers|September 1, 2019
Novel Human Bispecific Aptamer-Antibody Conjugates for Efficient Cancer Cell KillingMargherita Passariello, Simona Camorani, Cinzia Vetrei, et al.
The FEBS Journal|September 18, 2008
Differential binding of human immunoagents and Herceptin to the ErbB2 receptorFulvia Troise, Valeria Cafaro, Concetta Giancola, et al.
Breast Cancer Research and Treatment|June 8, 2012
Mechanisms of cardiotoxicity associated with ErbB2 inhibitorsCarmine Fedele, Gennaro Riccio, Angela Eliana Malara, et al.
Pageof 7